Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging and Metabonomics of TCM Subtypes in MDD
NCT02346682Phase 4Unknown
- Sponsor
- Tongde Hospital of Zhejiang Province
- Start
- Feb 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of venlafaxine in major depressive disorder (MDD) (3 arms), sponsored by Tongde Hospital of Zhejiang Province. Primary endpoint: Brain neuroimaging at 6 weeks. Status: unknown.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02346682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02346682.